Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis
Objective To investigated the clinical efficacy of Soluble thrombomodulin (sTM), tissue plasminogen activator inhibitor complex (t-PAI·C),thrombin-antithrombin complex (TAT),α2-plasmininhibitor-plasmin complex (PIC) in pediatric sepsis and pediatrics sepsis-induced coagulopathy (pSIC). Methods We pr...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-05-01
|
| Series: | Clinical and Applied Thrombosis/Hemostasis |
| Online Access: | https://doi.org/10.1177/10760296221102929 |
| _version_ | 1811247375414460416 |
|---|---|
| author | Juanzhen Li Jingyi Zhou Hong Ren Teng Teng Biru Li Ying Wang Long Xiang |
| author_facet | Juanzhen Li Jingyi Zhou Hong Ren Teng Teng Biru Li Ying Wang Long Xiang |
| author_sort | Juanzhen Li |
| collection | DOAJ |
| description | Objective To investigated the clinical efficacy of Soluble thrombomodulin (sTM), tissue plasminogen activator inhibitor complex (t-PAI·C),thrombin-antithrombin complex (TAT),α2-plasmininhibitor-plasmin complex (PIC) in pediatric sepsis and pediatrics sepsis-induced coagulopathy (pSIC). Methods We prospectively collected patient data with sepsis diagnosed in the PICU of Shanghai Children's Medical Center from June 2019 to June 2021. sTM,t-PAI·C, TAT,PIC and classical coagulation laboratory tests (CCTs) were evaluated on the day of sepsis diagnosis. Results Fifty-nine children were enrolled, There were significant differences in t-PAI·C (P = 0.001), Plt (P < 0.001), PT (P < 0.001), INR (P < 0.001), aPTT (P < 0.001), and TT (P = 0.048) between the pSIC and non-pSIC groups, logistic regression analysis showed that Plt (P = 0.032) was an independent risk factor for pSIC. Logistic regression analysis showed that sTM (P = 0.007) and Plt (P = 0.016) were independent risk factors for the outcome in pediatrics sepsis following discharge. The AUC of sTM combined with Plt on the mortality outcome of children with sepsis at discharge was 0.889 (95%CI: 0.781,0.956). which was better than that for PRISM III (AUC, 0.723), pSOFA (AUC, 0.764), and blood Lac (AUC, 0.717) when sepsis was diagnosed in the PICU. Conclusions The t-PAI·C increased in children with pSIC. The prediction of sepsis outcome using sTM combined with Plt was better than with PRISM III, pSOFA, or Lac.Further research is still needed in the future to explore the clinical value of sTM, TAT, PIC, and t-PAI·C in diagnosis and outcome of pediatrics sepsis and pSIC. |
| first_indexed | 2024-04-12T15:08:35Z |
| format | Article |
| id | doaj.art-6cbf8032eb8b49bfa929860e60408141 |
| institution | Directory Open Access Journal |
| issn | 1938-2723 |
| language | English |
| last_indexed | 2024-04-12T15:08:35Z |
| publishDate | 2022-05-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Clinical and Applied Thrombosis/Hemostasis |
| spelling | doaj.art-6cbf8032eb8b49bfa929860e604081412022-12-22T03:27:51ZengSAGE PublishingClinical and Applied Thrombosis/Hemostasis1938-27232022-05-012810.1177/10760296221102929Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric SepsisJuanzhen Li0Jingyi Zhou1Hong Ren2Teng Teng3Biru Li4Ying Wang5Long Xiang6 Department of Critical Care Medicine, , Shanghai Jiao Tong University, Shanghai, China Ren Ji Hostipal, Shanghai Jiao Tong University School of Medicine, Shanghai,China Department of Critical Care Medicine, , Shanghai Jiao Tong University, Shanghai, China Department of Critical Care Medicine, , Shanghai Jiao Tong University, Shanghai, China Department of Critical Care Medicine, , Shanghai Jiao Tong University, Shanghai, China Department of Critical Care Medicine, , Shanghai Jiao Tong University, Shanghai, China Department of Neonatal, Second People’s Hospital of Kashgar, Xinjiang Uygur Autonomous Region, ChinaObjective To investigated the clinical efficacy of Soluble thrombomodulin (sTM), tissue plasminogen activator inhibitor complex (t-PAI·C),thrombin-antithrombin complex (TAT),α2-plasmininhibitor-plasmin complex (PIC) in pediatric sepsis and pediatrics sepsis-induced coagulopathy (pSIC). Methods We prospectively collected patient data with sepsis diagnosed in the PICU of Shanghai Children's Medical Center from June 2019 to June 2021. sTM,t-PAI·C, TAT,PIC and classical coagulation laboratory tests (CCTs) were evaluated on the day of sepsis diagnosis. Results Fifty-nine children were enrolled, There were significant differences in t-PAI·C (P = 0.001), Plt (P < 0.001), PT (P < 0.001), INR (P < 0.001), aPTT (P < 0.001), and TT (P = 0.048) between the pSIC and non-pSIC groups, logistic regression analysis showed that Plt (P = 0.032) was an independent risk factor for pSIC. Logistic regression analysis showed that sTM (P = 0.007) and Plt (P = 0.016) were independent risk factors for the outcome in pediatrics sepsis following discharge. The AUC of sTM combined with Plt on the mortality outcome of children with sepsis at discharge was 0.889 (95%CI: 0.781,0.956). which was better than that for PRISM III (AUC, 0.723), pSOFA (AUC, 0.764), and blood Lac (AUC, 0.717) when sepsis was diagnosed in the PICU. Conclusions The t-PAI·C increased in children with pSIC. The prediction of sepsis outcome using sTM combined with Plt was better than with PRISM III, pSOFA, or Lac.Further research is still needed in the future to explore the clinical value of sTM, TAT, PIC, and t-PAI·C in diagnosis and outcome of pediatrics sepsis and pSIC.https://doi.org/10.1177/10760296221102929 |
| spellingShingle | Juanzhen Li Jingyi Zhou Hong Ren Teng Teng Biru Li Ying Wang Long Xiang Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis Clinical and Applied Thrombosis/Hemostasis |
| title | Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis |
| title_full | Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis |
| title_fullStr | Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis |
| title_full_unstemmed | Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis |
| title_short | Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis |
| title_sort | clinical efficacy of soluble thrombomodulin tissue plasminogen activator inhibitor complex thrombin antithrombin complex α2 plasmininhibitor plasmin complex in pediatric sepsis |
| url | https://doi.org/10.1177/10760296221102929 |
| work_keys_str_mv | AT juanzhenli clinicalefficacyofsolublethrombomodulintissueplasminogenactivatorinhibitorcomplexthrombinantithrombincomplexa2plasmininhibitorplasmincomplexinpediatricsepsis AT jingyizhou clinicalefficacyofsolublethrombomodulintissueplasminogenactivatorinhibitorcomplexthrombinantithrombincomplexa2plasmininhibitorplasmincomplexinpediatricsepsis AT hongren clinicalefficacyofsolublethrombomodulintissueplasminogenactivatorinhibitorcomplexthrombinantithrombincomplexa2plasmininhibitorplasmincomplexinpediatricsepsis AT tengteng clinicalefficacyofsolublethrombomodulintissueplasminogenactivatorinhibitorcomplexthrombinantithrombincomplexa2plasmininhibitorplasmincomplexinpediatricsepsis AT biruli clinicalefficacyofsolublethrombomodulintissueplasminogenactivatorinhibitorcomplexthrombinantithrombincomplexa2plasmininhibitorplasmincomplexinpediatricsepsis AT yingwang clinicalefficacyofsolublethrombomodulintissueplasminogenactivatorinhibitorcomplexthrombinantithrombincomplexa2plasmininhibitorplasmincomplexinpediatricsepsis AT longxiang clinicalefficacyofsolublethrombomodulintissueplasminogenactivatorinhibitorcomplexthrombinantithrombincomplexa2plasmininhibitorplasmincomplexinpediatricsepsis |